StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$941.25−6.27 (-0.66%)

Close on Nov 18, 2026Market cap –P/E 48.1Yield –

argenx gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2023 it was -$82.30M.

Annual gross profit

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$82.30M–
FY2022Dec 31, 2022-$19.41M–

More argenx figures

See a number that looks wrong?